Variant report
Variant | nsv611954 |
---|---|
Chromosome Location | chr8:114758203-114817903 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:114816422..114818283-chr8:114819579..114821682,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554552288 | chr8:114773426-114773427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35368068 | chr8:114773540-114773541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575052648 | chr8:114773575-114773576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534106624 | chr8:114773593-114773594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191359072 | chr8:114773613-114773614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149530951 | chr8:114773645-114773646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs539155171 | chr8:114773665-114773666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544052388 | chr8:114773673-114773674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556177366 | chr8:114773681-114773682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73704310 | chr8:114773712-114773713 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs535395708 | chr8:114773714-114773715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs3911267 | chr8:114773729-114773730 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs574772552 | chr8:114773766-114773767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs540560644 | chr8:114773770-114773771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560306026 | chr8:114773773-114773774 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200558187 | chr8:114773779-114773780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183172808 | chr8:114773813-114773814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568162755 | chr8:114773826-114773827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187855441 | chr8:114773895-114773896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144181382 | chr8:114773899-114773900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs115718889 | chr8:114773900-114773901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190796765 | chr8:114773901-114773902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148084774 | chr8:114773958-114773959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183097227 | chr8:114773986-114773987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187822496 | chr8:114773997-114773998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs28450774 | chr8:114774005-114774006 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs28685235 | chr8:114774018-114774019 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs191979307 | chr8:114774026-114774027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs28529276 | chr8:114774030-114774031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs141863940 | chr8:114774031-114774032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs72472058 | chr8:114774078-114774079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373006846 | chr8:114774125-114774126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535224671 | chr8:114774136-114774137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147259320 | chr8:114774154-114774155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565380390 | chr8:114774165-114774166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140826508 | chr8:114774212-114774213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554000254 | chr8:114774213-114774214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs114961429 | chr8:114774220-114774221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs530570122 | chr8:114774243-114774244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148407325 | chr8:114774244-114774245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184268882 | chr8:114774249-114774250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79362076 | chr8:114774278-114774279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375503259 | chr8:114774291-114774292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556504724 | chr8:114774328-114774329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs576464657 | chr8:114774349-114774350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs207469762 | chr8:114774368-114774369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188524346 | chr8:114774374-114774375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11996026 | chr8:114774378-114774379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs527636322 | chr8:114774408-114774409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371937763 | chr8:114774490-114774491 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:114773400-114775200 | Enhancers | Dnd41 | blood |
2 | chr8:114775400-114776000 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr8:114796000-114796400 | Enhancers | Dnd41 | blood |
4 | chr8:114796400-114798400 | Weak transcription | Dnd41 | blood |
5 | chr8:114798400-114799000 | Enhancers | Dnd41 | blood |
6 | chr8:114799000-114799400 | Flanking Active TSS | Dnd41 | blood |
7 | chr8:114799400-114799800 | Enhancers | Dnd41 | blood |
8 | chr8:114799800-114800800 | Flanking Active TSS | Dnd41 | blood |
9 | chr8:114800600-114801400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr8:114800800-114801200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr8:114800800-114802600 | Enhancers | Dnd41 | blood |
12 | chr8:114802600-114802800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr8:114802600-114803400 | ZNF genes & repeats | Dnd41 | blood |
14 | chr8:114802800-114803400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr8:114802800-114803400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr8:114803400-114803600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr8:114803400-114804400 | Weak transcription | Dnd41 | blood |
18 | chr8:114804400-114805200 | Enhancers | Dnd41 | blood |
19 | chr8:114805600-114806000 | Active TSS | Aorta | Aorta |
20 | chr8:114812800-114813000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |